Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
43 hedge funds and large institutions have $2.05M invested in Nymox Pharmaceutical Corp in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
13% more funds holding
Funds holding: 38 → 43 (+5)
0% more call options, than puts
Call options by funds: $12K | Put options by funds: $12K
49% less capital invested
Capital invested by funds: $4M → $2.05M (-$1.95M)
72% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$40.9K |
| 2 |
FTDI
First Trust Direct Indexing
Boston,
Massachusetts
|
+$18.1K |
| 3 |
LNC
Lincoln National Corp
Radnor,
Pennsylvania
|
+$16.5K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$14.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$236K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$136K |
| 3 |
E
Ergoteles
New York
|
-$133K |
| 4 |
Millennium Management
New York
|
-$74.6K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$39K |
NYMX Hedge Fund Activity: Q4 2021 in Review
43 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2021, worth a combined $2.05M — down 49% from $4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NYMX positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 18 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $40.9K. The largest seller was HRT Financial, exiting entirely with an estimated $236K sold.
- 43 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2021, up from 38 in Q3 2021.
- Funds reported $2.05M of Nymox Pharmaceutical Corp stock for Q4 2021, down 49% quarter-over-quarter.
- 9 funds opened new Nymox Pharmaceutical Corp positions in Q4 2021 and 4 closed out, a net change of +5 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q4 2021 was Jane Street, an estimated $40.9K added.
- The largest Nymox Pharmaceutical Corp seller in Q4 2021 was HRT Financial, an estimated $236K sold.
Based on aggregated 13F filings for Q4 2021.